TTC12 Inhibitors
TTC12 Inhibitors encompass a diverse range of compounds that can interfere with specific signaling pathways or cellular processes, thereby indirectly leading to the inhibition of TTC12. For example, staurosporine is a broad-spectrum kinase inhibitor that could impede the phosphorylation of TTC12 or its associated substrates. This action could prevent activation of TTC12, which is critical for its function. Similarly, inhibitors targeting specific kinase isoforms, such as Bisindolylmaleimide I for PKC and LY333531 for PKCβ, can suppress the activation cascade that might be essential for TTC12's functional activity. Since protein phosphorylation is a common post-translational modification that regulates protein activity, the inhibition of kinases that modify TTC12 or its interacting partners can have asignificant effect on TTC12's role in cellular processes.
Furthermore, inhibitors like H-89 that target PKA could diminish TTC12 activity if TTC12 is reliant on PKA for activation or is part of PKA-regulated pathways. Similarly, GSK-3 inhibitor SB216763 could suppress TTC12 function by altering pathways in which GSK-3 is a pivotal player. Inhibition of JNK by SP600125, or Rho-associated kinase by Y-27632, might also lead to reduced TTC12 activity if these kinases are upstream regulators of TTC12. Additionally, inhibitors like U73122, which target PLC, could disrupt phosphoinositide signaling, thereby potentially inhibiting TTC12. Wortmannin and LY294002, both PI3K inhibitors, could decrease TTC12 activity by preventing activation of the PI3K/AKT pathway, which may be necessary for TTC12 function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that can inhibit a wide range of protein kinases. TTC12's function may involve phosphorylation events, and staurosporine's broad inhibitory action on kinases can lead to decreased phosphorylation of TTC12 or its substrates, resulting in the inhibition of TTC12's functional activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
A specific inhibitor of protein kinase C (PKC) isoforms. If TTC12's activity is modulated by PKC-mediated signaling, the inhibition of PKC could result in reduced activation of TTC12, thereby inhibiting its function. | ||||||
LY-333,531 Hydrochloride | 169939-93-9 | sc-364215 sc-364215A | 1 mg 5 mg | $94.00 $287.00 | 6 | |
Also known as Ruboxistaurin, this compound is a selective inhibitor of PKCβ. If TTC12 is specifically regulated by PKCβ isozymes, LY333531's inhibition of these isozymes can lead to a decrease in TTC12's activity. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
A glycogen synthase kinase 3 (GSK-3) inhibitor. GSK-3 is involved in a multitude of signaling pathways, and if TTC12's function is GSK-3 dependent, inhibition by SB216763 could reduce TTC12 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that can prevent the activation of the JNK pathway. If TTC12's function is modulated by JNK signaling, inhibition by SP600125 could lead to a decrease in TTC12's activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor that impedes the Rho-associated protein kinase pathway. If TTC12's activity is influenced by ROCK signaling, the inhibition by Y-27632 could lead to a reduction in TTC12's functional activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that can inhibit the PI3K/AKT pathway. If TTC12's activity is regulated by this pathway, inhibition by wortmannin could result in decreased TTC12 activity by reducing phosphorylation or other post-translational modifications regulated by PI3K/AKT. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor, similar to wortmannin, which can lead to reduced activation of the PI3K/AKT pathway. If TTC12 is involved in this pathway, LY294002's action can result in diminished TTC12 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor which can disrupt the mTOR signaling pathway. If TTC12 is involved in signaling pathways downstream of mTOR, the inhibition of mTOR by rapamycin could lead to a decrease in TTC12's functional activity by altering downstream signaling events or protein interactions. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
An EGFR tyrosine kinase inhibitor. If TTC12's function is directly or indirectly regulated by EGFR signaling, inhibition by gefitinib could result in a decrease in TTC12's activity by preventing EGFR-mediated phosphorylation events or interactions. | ||||||